These breast cancer biomarkers are also interdependent, however; in particular, ER expression is inversely correlated with abnormal p53 [15], overexpression of ERBB2 [15], high Ki-67 and nuclear grade, and poor patient prognosis [17]. This evidence concerns the gene ERBB2 and breast cancer.